- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02821169
Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain (ROPI_POSTOP)
September 26, 2019 updated by: University Hospital, Lille
Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.
Endoscopic sinus surgery (ESS) is a prevalent surgical procedure.
It is required in many chronic rhinosinusitis for whom the medical treatment failed.
In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective randomized double blind placebo controlled study was designed. Local injection of ropivacaine or placebo was conducted at the end of the surgical procedure in both nasal fossa through endoscopic view in the sphenopalatine region.
Pain was measured in the postoperative course with visual analogic scale in the recovery room and the rhinologic department.
Study Type
Interventional
Enrollment (Actual)
184
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lille, France
- CHRU, Hôpital Claude HURIEZ
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients requiring endoscopic sinus surgery
- ASA score 1 or 2
- patients with health care insurance
- approved consent
Exclusion Criteria:
- any sinonasal malignant tumor
- renal failure, hepatic disorder, respiratory deficiency, cardiovascular diseases
- neurologic disorders
- alcohol or drugs addiction
- preoperative facial pain from an extranasal origin
- coagulation disorders
- antidepressive treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: saline solution 0.9%
injection of saline solution in the sphenopalatine area in both nasal fossa
|
injection of 4 mL of saline solution in the sphenopalatine area through an endoscopic approach
Other Names:
|
Active Comparator: ropivacaine (2mg/ml)
injection of ropivacaine in the sphenopalatine area in both nasal fossa
|
injection of 4mL of ropivacaine in the sphenopalatine area through an endoscopic approach
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual analog scale
Time Frame: at the 2 postoperative hours
|
Measure the intensity pain, in the group treated with Ropivacaine.
|
at the 2 postoperative hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analgesics consumption orally
Time Frame: during the 7 days post-surgery
|
patient-controlled administration
|
during the 7 days post-surgery
|
Administration of analgesics by parenteral route
Time Frame: at the 2 postoperative hours
|
patient-controlled administration
|
at the 2 postoperative hours
|
Visual analog scale for the intensity postoperative pain
Time Frame: at the 4 and at the 6 postoperative hours
|
patient-controlled administration
|
at the 4 and at the 6 postoperative hours
|
Visual analog scale for the during postoperative pain
Time Frame: At Morning and evening between the 1 and 7 days post surgery
|
self-assessment by the patient at home on the information collection book
|
At Morning and evening between the 1 and 7 days post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Goeffrey Mortuaire, MD, PhD, University Hospital, Lille
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2015
Primary Completion (Actual)
June 1, 2019
Study Completion (Actual)
June 1, 2019
Study Registration Dates
First Submitted
June 29, 2016
First Submitted That Met QC Criteria
June 29, 2016
First Posted (Estimate)
July 1, 2016
Study Record Updates
Last Update Posted (Actual)
October 1, 2019
Last Update Submitted That Met QC Criteria
September 26, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Neoplasms
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Cysts
- Connective Tissue Diseases
- Mucinoses
- Pain, Postoperative
- Ganglion Cysts
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anesthetics, Local
- Ropivacaine
Other Study ID Numbers
- 2013_07
- 2013-004410-17 (EudraCT Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
Clinical Trials on saline solution 0.9%
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Children's Hospital of PhiladelphiaCompletedSaline Solution, Hypertonic | Bronchiolitis, ViralUnited States
-
Federal University of UberlandiaUnknown
-
Kedrion S.p.A.inVentiv Health ClinicalTerminated
-
Fundacion Clinica Valle del LiliTerminatedAbdominal InjuriesColombia
-
State University of New York at BuffaloTerminatedDiabetic KetoacidosisUnited States
-
Menoufia UniversityCompletedCirculatory FailureEgypt
-
Sunnybrook Health Sciences CentreCompleted
-
Chulalongkorn UniversityNational Research Council of ThailandTerminated
-
Assiut UniversityNot yet recruitingFluid Resuscitation